CLINICAL STUDIES
We evaluate the efficacy and safety of clinical health interventions that generate wellness, in order to determine their global implementation.
| Year | Title of the Study |
| 1996 | Immunogenicity, reactogenicity, and safety of the candidate meningococcal B vaccine. |
| 2007 | V87P5: Immunogenicity, safety, and tolerability of FLUAD H5N1 influenza vaccine and the stationary influenza vaccine. |
| 2010 | A3L24: Batch-to-batch consistency of DTaP-IPV-HepB-PRP-T vaccine in children in concomitant application with prevenar and rotarix. |
| 2015 | NOR 202: Immunogenicity and safety of intramuscular bivalent norovirus vaccine. |
| 2016 | CYD65: safety and immunogenicity of tetravalent dengue vaccine. |
| Year | Title of the Study |
| 2021 | HERALD: Efficacy and safety of CVnCoV-2 mRNA vaccine to prevent Covid-19. |
| 2021 | SPECTRA: Efficacy, Immunogenicity and safety of SCB-2019 subunit s trimeric vaccine in the prevention against covid-19. |
| 2021 | MK1654-004 ASSERVO: efficacy and safety of MK 1654 monoclonal antibody against RSV, in healthy infants. |
| 2022 | Solidarity: International randomized trial of candidate vaccines against COVID-19. |
| Year | Title of the Study |
| 1995 | Immunogenicity and reactogenicity in varicella vaccine. |
| 1996 | Consistency of three lots of combined measles, rubella and mumps vaccine. |
| 1996 | Consistency Hib vaccine half dose in healthy infants. |
| 1997 | Immunogenicity and reactogenicity of quadrivalent vaccine (DTPw-HBV) and Haemophilus influenzae type b (hiB). |
| 2003 | Immunogenicity, efficacy and safety of 2 doses of oral rotavirus vaccine concomitant with PAI vaccines. |
| 2003 | Immunogenicity, efficacy and safety of 2 doses of oral rotavirus vaccine in healthy infants. |
| 2003 | Immunogenicity of 3 batches of oral rotavirus vaccine. |
| 2007 | V59P14: Safety and immunogenicity of meningococcal conjugate vaccine in children. |
| 2007 | V59P17 Safety and immunogenicity among meningococcal vaccines. |
| 2008 | COMPAS: To evaluate the efficacy of Pneumococcal 10 Valente vaccine in the prevention of CAP and AOM. |
| 2009 | Immunoreactivity and efficacy of adult meningococcal vaccine. |
| 2010 | HB vaccine, Polio, Measles in HIV positive children. |
| 2010 | H1N1: Safety and efficacy of H1N1 influenza vaccine in children. |
| 2011 | A3L27: persistence of antibodies to the combined DTaP-IPV-HepB-PRP-T or infanrix hexa vaccine after a primary series in children. |
| 2011 | CYD29 Group assignment study of tetravalent dengue vaccine concomitantly administered with stamaril vaccine in children. |
| 2013 | A3L28: Antibody persistence at 3, 5 and 4, 5 years of combined vaccine and DTaP-IPV-HepB-PRP-T or infanrix hexa booster after a primary series in children. |
| 2016 | DEN301: Efficacy, safety and immunogenicity of tetravalent vaccine against dengue. |
| 2019 | V114: Safety, tolerability and immunogenicity of pneumococcal vaccine in children with sickle cell anemia. |
| 2020 | ENSEMBLE: Efficacy and safety of Ad26.COV2.S vaccine for covid-19 prevention. |
| 2021 | MAT-009: Efficacy of a single dose of maternal RSV vaccine for the prevention of RSV-associated LRTI in infants. |
| 2021 | MELODY: Safety and efficacy of MEDI8897 against RSV in infants. |
| 2021 | VAT00008: Safety and immunogenicity of two recombinant SARS-CoV-2 protein vaccines (monovalent and bivalent) for prevention against COVID-19. |
| 2022 | DEN302 Booster: Tetravalent vaccine against dengue. |
| 2022 | ILUMINA: Immunogenicity and safety of seasonal influenza vaccine mRNA1010. |
| Year | Title of the Study |
| 1999 | Clinical and bacteriological efficacy of amoxacillin against group A beta-hemolytic streptococcal pharyngotonsillitis with 2 different doses in children. |
| 1998 | Clinical and bacteriological efficacy Cefproxil vs. Cefuroxime acetyl in AOM in children. |
| 2000 | Safety, reactogenicity and efficacy of linezolid vs vancomycin in severe resistant gram-positive infections. |
| 2000 | Anti-inflammatory response of Dexamethasone in children with meningitis. |
| 2006 | Efficacy of lactic ferments in EDA. |
| 2010 | Efavirenz, Didanosine and Emtricitabine in children with HIV. |
| 2013 | Safety, humoral and intestinal immunogenicity of IPV vaccine one or 2 additional doses. |
| 2021 | EPIC: Use of ivermectin in patients with covid-19. |
| Year | Title of the Study |
| 2003 | Prevalence of lipodystrophy, dyslipidemia in children with HIV. |
| 2006 | Hepatitis A seroprevalence in children and adolescents. |
| 2007 | Serotyping and antibiotic sensitivity in AOM. |
| 2020 | CYD82: Seronegative surveillance who received tetravalent dengue vaccine in CYD studies. |
| 2022 | MISC- Prognostic biomarkers in systemic inflammatory syndrome in children. |
| 2022 | LIVE: Active post-vaccination surveillance against covid-19. |
| Year | Title of the Study |
| 2015 | NOR EPI: Prevalence of norovirus gastroenteritis in cali. |
| 2019 | EPI-RSV-008: Epidemiologic RSV. |
| 2017 | Prospective and Zika case definition. |
